Tumor microenvironment and epithelial mesenchymal transition as targets to overcome tumor multidrug resistance.

Drug Resistance Updates : Reviews and Commentaries in Antimicrobial and Anticancer Chemotherapy
Nuray ErinThomas Efferth

Abstract

It is well established that multifactorial drug resistance hinders successful cancer treatment. Tumor cell interactions with the tumor microenvironment (TME) are crucial in epithelial-mesenchymal transition (EMT) and multidrug resistance (MDR). TME-induced factors secreted by cancer cells and cancer-associated fibroblasts (CAFs) create an inflammatory microenvironment by recruiting immune cells. CD11b+/Gr-1+ myeloid-derived suppressor cells (MDSCs) and inflammatory tumor associated macrophages (TAMs) are main immune cell types which further enhance chronic inflammation. Chronic inflammation nurtures tumor-initiating/cancer stem-like cells (CSCs), induces both EMT and MDR leading to tumor relapses. Pro-thrombotic microenvironment created by inflammatory cytokines and chemokines from TAMs, MDSCs and CAFs is also involved in EMT and MDR. MDSCs are the most common mediators of immunosuppression and are also involved in resistance to targeted therapies, e.g. BRAF inhibitors and oncolytic viruses-based therapies. Expansion of both cancer and stroma cells causes hypoxia by hypoxia-inducible transcription factors (e.g. HIF-1α) resulting in drug resistance. TME factors induce the expression of transcriptional EMT factors, MDR and metabo...Continue Reading

References

Nov 1, 1991·British Journal of Cancer·K SakataR M Sutherland
Apr 18, 1990·Journal of the National Cancer Institute·C K LukI F Tannock
Feb 28, 1995·Proceedings of the National Academy of Sciences of the United States of America·A J KoleskeM P Lisanti
Jun 1, 1994·Cancer Metastasis Reviews·B A Teicher
Mar 1, 1996·The Journal of Bone and Joint Surgery. American Volume·H TakeshitaH J Mankin
Sep 1, 1995·Annals of Oncology : Official Journal of the European Society for Medical Oncology·S C LinnJ P Baak
Dec 22, 1999·The Journal of Immunology : Official Journal of the American Association of Immunologists·M StolinaS M Dubinett
Sep 5, 2001·British Journal of Cancer·M R KaragasD W Nierenberg
Mar 21, 2002·Nature Reviews. Cancer·Michael M GottesmanSusan E Bates
Oct 3, 2002·Biochemical and Biophysical Research Communications·Takeshi NatoriMasatoshi Makuuchi
Jan 7, 2003·FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology·Maria WartenbergHeinrich Sauer
Oct 28, 2003·European Journal of Nuclear Medicine and Molecular Imaging·Seigo KinuyaNorihisa Tonami
Mar 27, 2004·The Journal of Biological Chemistry·Partha KrishnamurthyJohn D Schuetz
Apr 2, 2004·Nature Reviews. Cancer·J Blake BartlettAngus G Dalgleish
May 25, 2004·Genes & Development·Sonia VegaM Angela Nieto
Jun 9, 2004·Circulation·Marcel LeviHarry R Büller
Aug 18, 2004·Molecular and Cellular Biology·Masahiro KajitaPaul A Wade
Nov 9, 2004·Trends in Immunology·Alberto MantovaniMassimo Locati
Nov 24, 2004·The Journal of Immunology : Official Journal of the American Association of Immunologists·Samuel HuberManfred Blessing
Apr 6, 2005·The Journal of Experimental Medicine·Julien C MarieAlexander Y Rudensky
Apr 22, 2005·The Journal of Immunology : Official Journal of the American Association of Immunologists·Mojgan Ahmadzadeh, Steven A Rosenberg
May 14, 2005·Pharmacology & Therapeutics·Thomas Efferth, Manfred Volm
Sep 28, 2005·The Journal of Experimental Medicine·Paulo C RodriguezAugusto C Ochoa
Oct 6, 2005·Journal of Huazhong University of Science and Technology. Medical Sciences = Hua Zhong Ke Ji Da Xue Xue Bao. Yi Xue Ying De Wen Ban = Huazhong Keji Daxue Xuebao. Yixue Yingdewen Ban·Shu XiaXianglin Yuan
Dec 21, 2005·The Journal of Immunology : Official Journal of the American Association of Immunologists·Stephanie K BuntSuzanne Ostrand-Rosenberg
Jan 7, 2006·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Tanya GritskoRichard Jove
Oct 27, 2006·International Journal of Cancer. Journal International Du Cancer·Eri SasabeTokio Osaki
Oct 31, 2006·Nature Cell Biology·Jong In YookStephen J Weiss

❮ Previous
Next ❯

Citations

Oct 9, 2020·International Journal of Molecular Sciences·Haiyan DaiJie Ma
Dec 21, 2020·Phytomedicine : International Journal of Phytotherapy and Phytopharmacology·Mohamed-Elamir F HegazyThomas Efferth
Jan 12, 2021·Drug Resistance Updates : Reviews and Commentaries in Antimicrobial and Anticancer Chemotherapy·Luciana MoscaGianni Colotti
Oct 28, 2020·International Journal of Molecular Sciences·Casey D Stefanski, Jenifer R Prosperi
Feb 9, 2021·Drug Resistance Updates : Reviews and Commentaries in Antimicrobial and Anticancer Chemotherapy·M ChiappaG Damia
Mar 24, 2021·General Thoracic and Cardiovascular Surgery·Toshi Menju, Hiroshi Date
Mar 26, 2021·Drug Resistance Updates : Reviews and Commentaries in Antimicrobial and Anticancer Chemotherapy·Ting JiangYan Cheng
May 19, 2021·Archives of Toxicology·Javier De Las RivasAngélica Figueroa
Jun 1, 2021·Signal Transduction and Targeted Therapy·Lei ZhongShengyong Yang
Jun 3, 2021·International Journal of Molecular Sciences·Ying SunHao Hu
Jun 18, 2021·European Journal of Nuclear Medicine and Molecular Imaging·Frederik L GieselAndreas L Buck
Jun 28, 2021·Drug Resistance Updates : Reviews and Commentaries in Antimicrobial and Anticancer Chemotherapy·Lingyue GaoLihui Wang
Aug 11, 2021·BioFactors·Xiao FuMasoud Najafi
Aug 14, 2021·Phytomedicine : International Journal of Phytotherapy and Phytopharmacology·Jingfeng LiuJian Chen
Aug 28, 2021·Frontiers in Cell and Developmental Biology·Hua-Yang FanXin-Hua Liang
Nov 12, 2021·Expert Reviews in Molecular Medicine·Lei HanChaogang Yang

❮ Previous
Next ❯

Related Concepts

Related Feeds

Autophagy & Metabolism

Autophagy preserves the health of cells and tissues by replacing outdated and damaged cellular components with fresh ones. In starvation, it provides an internal source of nutrients for energy generation and, thus, survival. A powerful promoter of metabolic homeostasis at both the cellular and whole-animal level, autophagy prevents degenerative diseases. It does have a downside, however--cancer cells exploit it to survive in nutrient-poor tumors.

Autophagy & Model Organisms

Autophagy is a cellular process that allows degradation by the lysosome of cytoplasmic components such as proteins or organelles. Here is the latest research on autophagy & model organisms

Autophagy & Disease

Autophagy is an important cellular process for normal physiology and both elevated and decreased levels of autophagy are associated with disease. Here is the latest research.

Cancer Metabolism: Therapeutic Targets

Targeting the mechanisms by which cancer cells acquire energy for metabolic needs is a therapeutic target. Discover the latest research on cancer metabolism and therapeutic targets.

Related Papers

Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
Mana TakiMasaki Mandai
Molecules : a Journal of Synthetic Chemistry and Natural Product Chemistry
Bowen Du, Joong Sup Shim
Frontiers in Oncology
Ilias Georgakopoulos-SoaresApostolos Zaravinos
© 2021 Meta ULC. All rights reserved